Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $362.56 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $208.45 | 9 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $59.87 | 2 | $0 (2019) |
| PFIZER INC. | $49.38 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $17.11 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15.47 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $12.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.99 | 1 | Janssen Pharmaceuticals, Inc ($28.99) |
| 2023 | $20.05 | 1 | Janssen Pharmaceuticals, Inc ($20.05) |
| 2022 | $43.72 | 2 | Janssen Pharmaceuticals, Inc ($43.72) |
| 2019 | $175.86 | 7 | PORTOLA PHARMACEUTICALS, INC. ($59.87) |
| 2018 | $93.94 | 5 | Janssen Pharmaceuticals, Inc ($66.19) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $32.53 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 06/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $27.34 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/26/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/31/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/14/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEPHROLOGY | ||||||
| 02/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 316 | 609 | $220,408 | $46,734 |
| 2022 | 7 | 825 | 1,641 | $392,025 | $123,988 |
| 2021 | 8 | 800 | 1,623 | $344,174 | $133,597 |
| 2020 | 6 | 583 | 1,339 | $309,981 | $113,922 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 330 | $86,208 | $20,091 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 143 | $68,640 | $13,269 | 19.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 103 | 106 | $42,778 | $9,327 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $22,782 | $4,048 | 17.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 341 | 999 | $235,948 | $76,669 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 241 | 254 | $61,754 | $20,044 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 104 | 247 | $49,461 | $13,350 | 27.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $25,737 | $7,413 | 28.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 50 | 50 | $7,286 | $2,613 | 35.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $6,892 | $2,125 | 30.8% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 22 | 23 | $4,947 | $1,775 | 35.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 292 | 1,036 | $210,606 | $82,180 | 39.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 247 | 260 | $54,440 | $21,034 | 38.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 81 | $31,734 | $12,120 | 38.2% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 50 | 79 | $15,165 | $6,280 | 41.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 68 | $10,205 | $3,509 | 34.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 22 | 22 | $7,668 | $3,089 | 40.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 51 | 52 | $7,228 | $2,881 | 39.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 25 | 25 | $7,128 | $2,504 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 239 | 932 | $160,744 | $73,039 | 45.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 183 | 186 | $35,613 | $14,656 | 41.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 66 | 67 | $22,743 | $10,103 | 44.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 15 | 54 | $68,305 | $9,337 | 13.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 52 | 72 | $12,544 | $4,044 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 28 | 28 | $10,032 | $2,743 | 27.3% |
About Dr. Charles Olisa, MD
Dr. Charles Olisa, MD is a Internal Medicine healthcare provider based in Cedar Hill, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265582837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Olisa, MD has received a total of $362.56 in payments from pharmaceutical and medical device companies, with $28.99 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($362.56).
As a Medicare-enrolled provider, Olisa has provided services to 2,524 Medicare beneficiaries, totaling 5,212 services with total Medicare billing of $418,242. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Hospitalist
- Location Cedar Hill, TX
- Active Since 01/12/2007
- Last Updated 01/11/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265582837
Products in Payments
- XARELTO (Drug) $208.45
- ANDEXXA (Biological) $59.87
- ELIQUIS (Drug) $49.38
- ENTRESTO (Drug) $17.11
- LifeVest (Device) $15.47
- SAMSCA (Drug) $12.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cedar Hill
Dr. Penny West, Md, MD
Internal Medicine — Payments: $4,729
Cecil Bailey, Md, MD
Internal Medicine — Payments: $2,233
Dr. Karuna Vangala, Md, MD
Internal Medicine — Payments: $1,780
Donald Phillips, M.d, M.D
Internal Medicine